Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The treatment of neuromyelitis optica.
I-BET151 selectively regulates IL-6 production.
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Neuromyelitis optica spectrum disorders may be misdiagnosed as Wernicke's encephalopathy.
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis.
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Alpha lipoic acid enhances endogenous peroxisome proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis.
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Seropositive Neuromyelitis Optica: A Pediatric Case Report and 6-Year Follow-Up.
Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Current and new directions in MRI in multiple sclerosis.
Pages
« first
‹ previous
…
467
468
469
470
471
472
473
474
475
…
next ›
last »